Heilongjiang Zbd Pharmaceutical Co.,Ltd.’s Net Profit Rose 41.8% in First Half of 2023

Heilongjiang Zbd Pharmaceutical Co.,Ltd. (黑龙江珍宝岛药业股份有限公司) (603567.SH) reported a net profit of 344.8 million yuan in the first half of 2023, up 41.8% year-on-year.

Meanwhile, the company posted 2.6 billion yuan in revenue, up 4.4% year-on-year.

At the end of the reporting period, it had 12.2 billion yuan in total assets and 4.8 billion yuan in total liabilities, with a liability-to-asset ratio of 39%.